Microsaic Systems Share Discussion Threads

[bobmonkeyhouse] 12/3/2018 10:22

UKOG has so far not proven anything ....it was a classic pump and dump

[bobmonkeyhouse] 12/3/2018 10:22

pump and dump court complaint

[bobmonkeyhouse] 12/3/2018 10:18

Pump and dump arrests

[moneymunch] 12/3/2018 10:14

A multi-bag in the making from this bargain low share price ..Gla holders:-)

Q5: So, what does your strategy as a group look like for the next 12 months?

A5: We are going to be launching fully, what we call, the 4500 product this year so that means that we can not only measure small molecules but also metabolites, peptides and small proteins and this is important to us because it enables us to talk to many more, and wider set, of OEM’s. We do also have a very existing tool-less technology and development and we feel this is truly unique and we think it’s going to be revolutionary in product maintenance, it will reduce maintenance from typically hours down to minutes. However, our key focus, as I said, is really on bioprocessing and we are targeting to have that concept ready towards the end of 2018.

On the commercial side, we are encouraged by progress since taking on the position of having more OEM partnerships and I remain hopeful to see a proportion of these converting this year, particularly in the second half.

[bobmonkeyhouse] 12/3/2018 10:14

always be careful where there is a resident ramper....especially one that has been part of a pump and dump

sfo/fca/fbi closed down beaufort and arrested people for pump and dump

[moneymunch] 12/3/2018 10:11

Only 181m shares in issue with the majority held by institutional investors and so maybe only as few as 40m shares in free float... £3m plus cash in the bank and enough working capital until Q1 2019...cutting edge minaturized mass spectrometry technology and protected by 60 patents...and currently in an ongoing collaboration agreement with a global biopharma partner where Microsaic's technology has been validated by their partner's BIG pharma end users and is being integrated into their partner's product equipment...A game changer and multi-bag in the making on a successful outcome...Gla holders On and Up!!! :-)

[moneymunch] 12/3/2018 10:09

Lol... shut it Stephanie, you desperate saddo troll gimp....Gla holders...Good news could drop at anytime...Tick Tock;-)

[stephen2010] 12/3/2018 09:50

No interest what so ever at low 2's. This is going sub 2p I'm afraid. All pie in the sky stuff here and lots of fundings required to bring anything tangible to the table. 1.5p may be worth a punt but steer clear anything north of that

[noirua] 11/3/2018 02:32

Price looks low and might well be worth a punt at this level. MSYS is known to recover very fast. Think carefully guys.

[bobmonkeyhouse] 10/3/2018 12:54

Post on ukog:

"To be fair , I don't think WTD is a con artist. A con artist would have sold at the top."

You mean like David Lenigas, MoneyMunch etc. ?

Oh no sorry wait a moment they still hold all their shares right?

[moneymunch] 09/3/2018 12:08

"advent of miniaturized mass spectrometers"


7/3/18

The prosperity of the global mass spectroscopy market, which is projected for a healthy CAGR during the forecast period of 2015 to 2023, can be attributed to a number of factors such as growing food safety concerns, new international GMP and GDP certification for pharmaceutical excipients, advent of miniaturized mass spectrometers and hybrid mass spectrometers, other technological advancements, and increasing government investments in a number of developed countries.

[moneymunch] 09/3/2018 07:50

Microsaic
‏ @Microsaic
28m28 minutes ago

Meet us at ASMS this June, come and go to us about Mass Directed analysis!
0 replies 1 retweet 1 like

Small, powerful and robust, the MiD 4500 is easily integrated into your separation workflow. Also talk to us about our exciting work in bioprocessing.

[moneymunch] 09/3/2018 07:15

Strategic Progress

During 2017, significant progress has been made in realigning the primary focus of the Company on applications in the growing biopharma market. In April we signed an amended agreement with one of the foremost players in the global market for scientific instrumentation. Following the successful completion of phase one, we signed a further extension to our collaboration in December. This second phase is expected to be completed in H2 2018, and our goal is to follow this with full phase three product development. This alone would represent a major commercial opportunity for the Company. During 2017, we have also continued to develop relationships with other partners to add further sales opportunities in the biopharma market.



The Company has a strong product development programme aimed at supporting its bioprocessing applications and maintaining its leading position in miniaturised mass spectrometer detection instruments and technologies. Enhancements currently in the pipeline will further extend the mass range for biologics detection, and introduce new capabilities, such as on-line desalting, which allows for the purification of biomolecules in real time.

[moneymunch] 09/3/2018 07:12

GE Healthcare - The company is developing a nanofiber-based purification technology platform for biopharmaceutical manufacture.

Microsaic

Q6: Talking about later dates, what have we got to look forward to in terms of the near-future for Microsaic Systems?

A6: Well, watch this space. We've got some really fantastic enabling technology underway for protein and peptide purification and what we're doing is taking a much more back-to-basics innovative approach to end user even use, this, along with some great partnerships, will hopefully make 2018 very exciting.

We've also previously announced that we have a triple quadrupole prototype which will be really a powerful tool in our point of care diagnostics armoury and more of that to follow.

[moneymunch] 09/3/2018 06:36

Here's a clue from Microsaic....GLA HOLDERS!!! ;-)

Microsaic Retweeted
ElizabethBergstedt
‏ @MzBergstedt
17h17 hours ago

Christel Fenge, Head of R&D for BioProcess, GE Healthcare Life Sciences connects company's history to its future business strategy in Uppsala BIO's article.

.....................................

GE Healthcare is Uppsala’s largest private employer. Uppsala BIO and GE Healthcare have enjoyed a long history of collaboration from strategic level to individual projects and events. Head of R&D Christel Fenge connects company history to future business strategies.

Christel Fenge, Head of R&D for BioProcess, GE Healthcare Life Sciences, is a relatively recent recruit having started in mid-2017 at the company’s site in Uppsala. With several years of experience from the bioprocess sector and a background in biotech research, it is easy to understand the appointment. Christel has extensive knowledge of the industry as well as the tools used in bioprocess development and manufacturing, including product management, process analysis and automation.

“After working the last few years at a German company focusing on product management of their bioreactor portfolio, I was eager to face new challenges and move closer to research and development again.”

Collaboration as a strategy

GE Healthcare is always on the look out for collaboration, and innovative ideas or techniques developed by academia and start-up companies are especially interesting. One recent example is Puridify, a UK-based bioprocessing start-up that GE acquired in November. The company is developing a nanofiber-based purification technology platform for biopharmaceutical manufacture.

[rackers1] 08/3/2018 22:21

Answer it Dutch pig filth

[moneymunch] 08/3/2018 20:33

Lol...you couple of bell ends...tell that to Nigel and Co......Ho Ho Ho....Gla holders, plenty more upside coming as the smart Money continues to accumulate...Tick Tock;-)

Number of securities in issue:
As at 31 December 2017: 181,365,146
Number of AIM securities held in treasury: None
Percentage of issued AIM securities not in public hands: 36.31%

Identity and percentage holdings of significant shareholders (3% and above):
As at 31 December 2017, the Company has been informed of the following holdings:

 Shareholder  %   Parkwalk Advisors Funds29.91  Octopus Investments  9.98  Fidelity International  9.54  Herald Investment Management  6.73  Nigel Wray  4.53  Directors  4.40  Hargreaves Lansdown  3.74  Interactive investor  3.13  

[boxerdogz] 08/3/2018 19:40

Plenty of SUB PUMPERS on this site lol

[boxerdogz] 08/3/2018 19:40

A MUST read article for all the Dunces !

Great post Bob

[bobmonkeyhouse] 08/3/2018 18:32

Part of a pump and dump is regularly telling punters there aren't many free float shares in issue. Beware the scum poster